Promega Launches COVID-19 Serology Test: Lumit™ Dx SARS-CoV-2 Immunoassay Workflow is Quick, Simple and Scalable for High-Throughput Antibody Detection

Madison, WI USA. (August 11, 2020) Promega Corporation today announced the launch of its new serological antibody test for COVID-19 to detect the presence of antibodies against the SARS-CoV-2 virus. A positive result may indicate whether an individual has been exposed to, and mounted an immune response to, the virus. Promega has submitted an application to the US... Read more

Bio-Techne and Nanostring Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler

Curated Menu of Off-the-Shelf RNAscope Probes Provide Molecularly-Guided Region of Interest Selection for Use with the New NGS-Enabled Cancer Transcriptome Atlas MINNEAPOLIS and SEATTLE, Aug. 6, 2020 /PRNewswire/ — Bio-Techne (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic markets and NanoString Technologies, Inc. (NASDAQ:NSTG), a leading... Read more

The United States Court of Appeals for the Federal Circuit Affirms that 10x Genomics Willfully Infringed Bio-Rad U.S. Patent and Upholds Lower Court’s Award of Damages

HERCULES, Calif. –Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced that the The United States Court of Appeals for the Federal Circuit today affirmed that 10x Genomics willfully infringed U.S. Patent 8,889,083, exclusively licensed to Bio-Rad from the University of Chicago. The Appeals Court upheld... Read more

Fluidigm and De Novo Software to Offer Mass Cytometry Customers a Streamlined Solution for Data Analysis

License for De Novo Software’s FCS Express 7 Flow to be Provided to Customers Purchasing Fluidigm Helios and Hyperion Imaging Systems SOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq: FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a distribution agreement with De Novo Software™... Read more

Bio-Techne and Kantaro Biosciences to Launch a Quantitative Research Use Only COVID-19 Serology Test

MINNEAPOLIS and NEW YORK, Aug. 3, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a joint commercialization and distribution team... Read more

Bio-Techne Announces Appointment of Julie L. Bushman to Its Board of Directors

MINNEAPOLIS, Aug. 3, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the appointment of Julie L. Bushman to serve as an independent director on the company’s board of directors, effective as of July 31, 2020.  Following the appointment, the board of Bio-Techne will be comprised of ten directors, nine of whom are independent.  Bushman, 59, is the former... Read more

HORIBA announces the launch of EasyImage, a new imaging tool for Raman microscopy

Expert level Raman Images for Everyone with EasyImage™ Palaiseau, Saclay Campus, France, July 30th, 2020 –  HORIBA, a global leader in measurement and analysis solutions for advanced research and industry, and the world leader in Raman microscopy and nanoscopy, is thrilled to announce the launch of EasyImage™, a new imaging tool for Raman microscopy. EasyImage™ is a... Read more

Zymo Research Releases Free Software to Streamline COVID-19 Test Reporting

CALIFORNIA LABORATORIES CAN NOW INSTANTLY TRANSMIT COVID-19 DATA TO THE CALREDIE SYSTEM IRVINE, Calif., (July 28, 2020) — Zymo Research recently has released a free open-source software program that allows California laboratories to rapidly report COVID-19 test data to the California Reportable Disease Information Exchange (CalREDIE). According to the California Department of Public Health (CDPH) website,... Read more

Bio-Techne Announces Launch of Exocovid-19 Test for Detection of SARS-CoV-2 in Patient Samples

MINNEAPOLIS, July 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus (SARS-CoV-2) and now offers the ExoCovid-19 test for detection of the virus in patient samples. The ExoCovid-19 test will be performed in its CLIA-certified, CAP-accredited laboratory. Exosome Diagnostics, the... Read more

Bio-Techne Announces Commercial Release of New Assay for Detecting ASOs, miRNAs, and siRNAs in Tissue

Expanding research tools to detect small non-coding RNAs in situ by combining molecular information with spatial context. MINNEAPOLIS, July 20, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope™ platform with the release of the miRNAscope™ Assay. The RNAscope technology is an advanced in situ hybridization assay for the spatial visualization... Read more